This site provides INTERCEPT product information for Health Care Professionals in the United States.

Cerus Webinars

Stanford Blood Center: Implementing a 100% Pathogen Reduced Platelet Inventory

Runtime: ~7min

Stanford discusses its experience with adopting a 100% pathogen reduced inventory to streamline production and to meet increasing hospital demand.

Dan Gross
Chief Operating Officer
, Stanford Blood Center

Harry Sussman
Director of Operational Excellence
, Stanford Blood Center

Read the Case Study: 

Stanford Blood Center – The First Blood Center of its Size to Implement Pathogen Reduction for 100% of Platelet Components

Stanford Blood Center (SBC), a leader in the fields of transfusion and transplantation medicine, supplies >17,000 platelet products per year to Stanford and other area hospitals.